Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.

作者: D. T. Kobayashi , K. S. Chen

DOI: 10.1111/J.1601-183X.2005.00124.X

关键词:

摘要: Alzheimer's disease (AD) is the most common neurodegenerative affliction of elderly, presenting with progressive memory loss and dementia terminating death. There have been significant advances in understanding biology subsequent diagnosis AD; however, furious pace research has not yet translated into a disease-modifying treatment. While scientific inquiry AD largely centered on identifying biological players pathological mechanisms, day-to-day realities patients their caregivers revolve around steady heartbreaking cognitive decline. In past decade, fundamentally transformed by development genetically modified animal models amyloid-driven neurodegeneration. These important vivo only replicate some hallmark pathology disease, such as plaque-like amyloid accumulations astrocytic inflammation, but also impairments relevant to AD. this article, we will provide detailed review behavioral deficits present several transgenic mouse discuss functional changes response experimental treatments.

参考文章(121)
Hui Zheng, Minghao Jiang, Myrna E. Trumbauer, Dalip J.S. Sirinathsinghji, Ruth Hopkins, David W. Smith, Robert P. Heavens, Gerard R. Dawson, Susan Boyce, Michael W. Conner, Karla A. Stevens, Hilda H. Slunt, Sangram S. Sisodia, Howard Y. Chen, Lex H.T. Van der Ploeg, β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity Cell. ,vol. 81, pp. 525- 531 ,(1995) , 10.1016/0092-8674(95)90073-X
Debby Van Dam, Rudi D'Hooge, Matthias Staufenbiel, Chris Van Ginneken, Frans Van Meir, Peter P. De Deyn, Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. European Journal of Neuroscience. ,vol. 17, pp. 388- 396 ,(2003) , 10.1046/J.1460-9568.2003.02444.X
C. L. Masters, G. Simms, N. A. Weinman, G. Multhaup, B. L. McDonald, K. Beyreuther, Amyloid plaque core protein in Alzheimer disease and Down syndrome Proceedings of the National Academy of Sciences of the United States of America. ,vol. 82, pp. 4245- 4249 ,(1985) , 10.1073/PNAS.82.12.4245
S. Lammich, E. Kojro, R. Postina, S. Gilbert, R. Pfeiffer, M. Jasionowski, C. Haass, F. Fahrenholz, Constitutive and regulated α-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 3922- 3927 ,(1999) , 10.1073/PNAS.96.7.3922
Ishrut Hussain, David Powell, David R. Howlett, David G. Tew, Thomas D. Meek, Conrad Chapman, Israel S. Gloger, Kay E. Murphy, Christopher D. Southan, Dominic M. Ryan, Trudi S. Smith, David L. Simmons, Frank S. Walsh, Colin Dingwall, Gary Christie, Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase Molecular and Cellular Neuroscience. ,vol. 14, pp. 419- 427 ,(1999) , 10.1006/MCNE.1999.0811
Hans-Gert Bernstein, Alicja Bukowska, Dieter Krell, Bernhard Bogerts, Siegfried Ansorge, Uwe Lendeckel, Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome. Journal of Neurocytology. ,vol. 32, pp. 153- 160 ,(2003) , 10.1023/B:NEUR.0000005600.61844.A6
David L King, Gary W Arendash, Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiology & Behavior. ,vol. 75, pp. 627- 642 ,(2002) , 10.1016/S0031-9384(02)00639-X
Hiroaki Fukumoto, Douglas L. Rosene, Mark B. Moss, Susan Raju, Bradley T. Hyman, Michael C. Irizarry, β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain American Journal of Pathology. ,vol. 164, pp. 719- 725 ,(2004) , 10.1016/S0002-9440(10)63159-8